In the European Union (EU or Europe), the European Medicines Agency (EMA) handles warning labels on drugs, while the Food and Drug Administration (FDA) handles labels in the United States
IV: 2-4 weeks
Better blood sugar control means fewer energy crashes, reduced cravings, and more stable energy throughout the day
The study found GLP-1 (7-36) to be more potent than GIP in stimulating the release of insulin
Several preclinical and animal studies have suggested that GLP-1RAs may have neurotrophic and neuroprotective effects, by reducing neuroinflammation, oxidative stress, apoptosis, and mitochondrial dysfunction and by promoting the growth and repair of neural cells, potentially enhancing cognitive functions [73,74,75]
Li J, Sun M, Liu L, et al